Top Markets
Coin of the day
OptiNose, Inc. OptiNose, Inc.

OptiNose, Inc.

OPTN
Rank in Stocks #9145
OptiNose, Inc. is a specialized pharmaceutical company primarily focused on... OptiNose, Inc. is a specialized pharmaceutical company primarily focused on innovating and bringing to market treatments for individuals under the care of ear, nose, throat, and allergy specialists throughout the United States. Its flagship product, XHANCE, utilizes the company's proprietary exhalation delivery system (EDS) to administer a topically-acting corticosteroid. This therapy is approved for treating chronic rhinosinusitis when accompanied by nasal polyps and is currently undergoing Phase IIIb clinical trials for broader chronic sinusitis treatment. The company also offers Onzetra Xsail, a powder-based EDS device, which is commercialized via a licensing agreement with Currax Pharmaceuticals LLC. Further expanding its pipeline, OptiNose is developing OPN-019, an investigational product that integrates a liquid EDS device with an antiseptic agent. Additionally, OptiNose has formed a partnership with Inexia Limited. This collaboration centers on the development, manufacturing, importation, and sale of products containing orexin receptor agonist or positive modulator molecules, intended for the treatment, diagnosis, or prevention of human conditions predominantly linked to orexin receptor activity. Established in 2000, OptiNose, Inc. operates from its corporate headquarters in Yardley, Pennsylvania.
Share Price
$9.60
Last synced: 2025-05-21
Market Cap
$1.08B
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade OptiNose, Inc. (OPTN)

Category

Stock split history for OptiNose, Inc. (OPTN)
OptiNose, Inc. stock (symbol: OPTN) underwent a total of 1 stock splits.
The most recent stock split occurred on Dec 31, 2024.
One OPTN share bought prior to Dec 31, 2024 would equal to 0.066666666666667 OPTN shares today.
Stock split list
Year Split Multiple Cumulative Multiple
2024-12-31 1:15 x0.066666666666667 x0.066666666666667
Stock splits for similar companies or competitors